HEPATIC INSUFFICIENCY
Clinical trials for HEPATIC INSUFFICIENCY explained in plain language.
Never miss a new study
Get alerted when new HEPATIC INSUFFICIENCY trials appear
Sign up with your email to follow new studies for HEPATIC INSUFFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver function and drug dosing: a closer look at ulonivirine
Knowledge-focused Not yet recruitingThis study investigates how a single dose of the drug ulonivirine is processed by the body in people with mild or moderate liver impairment compared to healthy volunteers. Researchers measure drug levels in the blood over time to see if liver function affects how the drug is brok…
Matched conditions: HEPATIC INSUFFICIENCY
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
New drug safety check: how does anaprazole affect liver, kidney, and elderly patients?
Knowledge-focused Not yet recruitingThis study looks at how the drug anaprazole sodium is processed by the body and whether it is safe for people with liver or kidney issues, as well as for older adults. About 60 participants will be enrolled to measure drug levels and track any side effects. The goal is to underst…
Matched conditions: HEPATIC INSUFFICIENCY
Phase: PHASE4 • Sponsor: Xuanzhu Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC